The Efficacy of Mesenchymal Stem Cell Therapy in Large Animal Models of Acute Liver Failure: A Meta-Analysis
/kg was associated with a significantly higher survival rate, as well as a lower AST level after treatment. In summary, the findings suggest MSC therapy is a safe and potential therapeutic option for large animals with ALF, although randomized controlled trials (RCTs) are needed for further validation.
Authors
- Yechao Lu
- Yan Yu (ORCID: https://orcid.org/0000-0001-8446-7561)
- Yuxin Zhang (ORCID: https://orcid.org/0009-0000-6729-0004)
- Shanwei Yang
- Xiaoping Pan
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3390/ijms27073175
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Zhejiang Province